A retrospective analysis of anti–B-cell maturation antigen (BCMA) chimeric antigen receptor T-cell (CAR T) therapy outcomes ...
Soluble TAM receptors (sTAMs) could serve as biomarkers for RA, indicating disease activity, severity, and prognosis, though standardized detection methods are needed. TAM receptors could emerge as ...
A new study reports that a routine, low-cost nutritional assessment tool may offer a powerful way to predict survival in patients with progressive pulmonary fibrosis (PPF), a life-shortening condition ...
GDF15 and OPN show promise in differentiating uterine sarcoma from leiomyoma, outperforming traditional markers like LDH and ...
Treadmill stress echocardiography (TSE) reveals hidden physiologic limitations in patients with asymptomatic hypertrophic cardiomyopathy (HCM), aiding in diagnosis and prognosis. Many patients with ...
In an interview with The American Journal of Managed Care® ( AJMC®), Mike Camacho, president of SLTCM, identifies 5 key strategies that ACOs can utilize to improve care and achieve meaningful savings, ...
Panelists discuss how global LDL thresholds below 55 mg/dL influence care and challenge U.S. practice to evolve. Stay ahead ...
Panelists discuss how nonstatin agents are chosen and when combination therapy should be introduced for high-risk patients.
Nerandomilast, a PDE4 inhibitor, has shown significant efficacy in progressive pulmonary fibrosis (PPF), offering an ...
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
The BMP8A Fibrosis Score (BFS) offers improved accuracy over existing noninvasive scoring systems for identifying advanced liver fibrosis in MASH patients. BFS eliminates grey-zone results, providing ...
Artificial intelligence (AI) is rapidly reshaping the landscape of leukemia diagnosis, offering new possibilities for earlier detection, more precise classification, and improved patient care, ...